Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Business & Regulation Advanced Medicine

Gearing Up for the 2022 Power List and More

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Business & Regulation Business Practice

Inside the PenCycle Recycling Scheme

Novo Nordisk explains how its pilot scheme in the UK is helping to recycle injector pens.

Manufacture Ingredients

Don't Get a Raw Deal

| Hunter Malanson

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

Manufacture Biosimilars

Driving Down Biosimilar COGS

| Amanda Turner, Khaled Mriziq

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

Manufacture Advanced Medicine

Can Cell Therapies Take on Solid Tumors?

| Stephanie Vine

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

Manufacture Bioprocessing - Upstream & Downstream

Keep Calm and Use Pools

| Trent Munro

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.

Manufacture Technology and Equipment

The Innovation Awards 2021

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.

Business & Regulation Supply Chain

Building Resilience in the Supply Chain

| Sponsored by Thermo Fisher Scientific

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

Business & Regulation Supply Chain

Strengthening Supply Chains Post-Pandemic

| Sponsored by Thermo Fisher Scientific

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

Manufacture Bioprocessing - Upstream & Downstream

A New Focus for Cancer Therapeutics

| Joe Sinclair

Joe Sinclair gives his view on how to be successful with oncolytic virotherapy.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register